Grifols Stock Market Boost After COVID-19 Drug Announcement

GRIFOLS stock market boost after the company makes COVID-19 drug announcement. The Grifol shares on the Spanish stock market shot up after they announced that clinical trials will begin.

Their new anit-covid drug is claimed to have an immediate effect and is said to give immunity from coronavirus. The drug could possibly be aimed at people unable to have the current vaccines due to contraindications, as it uses a plasma protein.

It is hoped that the clinical trial will start in February and results could be seen as soon as spring.

Thank you for taking the time to read this news article “Grifols Stock Market Boost After COVID-19 Drug Announcement”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.


FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Alex Glenn

Originally from the UK, Alex is based in Almeria and is a web reporter for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at [email protected]


    Leave a comment

    Your email address will not be published. Required fields are marked *